MPOCEF CV-50 DRY SYRUP

Cefpodoxime acts by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. It is highly effective against respiratory tract pathogens, urinary pathogens, and skin and soft tissue bacteria. However, some bacteria produce β-lactamase enzymes that can deactivate many antibiotics. Clavulanic Acid, a β-lactamase inhibitor, counteracts this resistance mechanism by binding to these enzymes, thereby protecting Cefpodoxime from degradation and restoring its antibacterial activity. This synergistic combination ensures strong and reliable infection control.

MPOCEF CV-50 Dry Syrup is indicated for the treatment of respiratory tract infections, otitis media, sinusitis, pharyngitis, tonsillitis, urinary tract infections, and skin and soft tissue infections in pediatric patients. It provides quick symptom relief by targeting the root cause of infection and helps reduce fever, inflammation, and discomfort effectively. Its pleasant-tasting formulation ensures better palatability and compliance among children, making it easier for parents to administer the prescribed dose.

Manufactured under stringent quality and safety standards, MPOCEF CV-50 Dry Syrup ensures consistent potency, stability, and bioavailability. It is well tolerated by children when used under pediatric guidance. With its proven efficacy, excellent safety profile, and child-friendly formulation, MPOCEF CV-50 Dry Syrup offers a dependable solution for managing common bacterial infections in children — promoting faster recovery and restoring health with care and confidence.